Sleeping is so easy you could, well, do it in your sleep. For now, anyway – you may not always have it so good. By our twilight years many of us...
The joy of scientific discovery, converging disease mechanisms, and failures of communication: Dr Gordon Lithgow on the past and present of geroscience (part II)
Dr. Gordon Lithgow of the Buck Institute for Research on Aging, who spoke to us recently about the Caenorhabditis Intervention Testing Program, talks ...
Dr. Gordon Lithgow on conflicting results in longevity studies, the origins of the CITP, and more (part I)
Dr. Gordon Lithgow got in on the ground floor of aging research in the lab that discovered the first anti-aging mutation, age-1, and has spent the 25 ...
Rapamycin: An impressive geroprotector with a few potential flaws
If any drug has performed consistently and unequivocally well in anti-aging trials, it’s rapamycin. Dr. Matt Kaeberlein’s Dog Aging Project is among t...
Best friends forever: Matt Kaeberlein on helping dogs live longer
Dr. Matt Kaeberlein, an aging researcher and professor at the University of Washington, is the director of the Dog Aging Project. This two part progra...
When copy-paste attacks: A possible answer to the mystery of Alzheimer’s disease
The first thing you’ll notice if you look at existing treatments for Alzheimer’s disease is that they don’t work. The second thing you’ll notice is th...
Your DNA ages too: Genomic instability as a hallmark of aging
Part of the Hallmarks of Aging series. The cells in our bodies are constantly churning out proteins and other structures, built according to the bluep...